Isomorphic Labs
Mentioned in 14 analyzed podcast episodes across 10 shows
A DeepMind spinoff company focused on AI-driven drug discovery and therapeutic development, leveraging proprietary versions of AlphaFold technology to tackle disease targets and accelerate pharmaceutical research. The company has partnered with major pharmaceutical firms like Novartis to apply its AI models to previously undruggable targets, and has demonstrated significant performance improvements on key drug discovery benchmarks. Podcasters discuss Isomorphic Labs as a notable example of how foundational AI research is being commercialized for real-world biomedical applications.
Mentioned On
Episode Mentions
TBPN · Aug 6, 2026
More Details on OpenAI-Hugging Face, SpaceX SPV Investors Get Rugged, Demis and DeepMind | Diet TBPN
“Demis Hassabis is expected to focus on Isomorphic Labs following his step back from DeepMind operations.”
The AI Daily Brief: Artificial Intelligence News and Analysis · Aug 6, 2026
Google’s AI Leadership Shakeup: Disaster or Exactly What It Needs?
“Drug discovery spinoff where Demis Hassabis will remain CEO and focus his scientific efforts.”
TBPN · Aug 5, 2026
Demis Is Out as DeepMind CEO, Apple Escalates OpenAI Suit, Spider-Man Sets Record | Diet TBPN
“Hassabis is leaning into his role here post-DeepMind CEO transition, focused on AI-driven disease cures.”
TBPN · Aug 5, 2026
Google DeepMind Reorgs, Rainforest Discoveries, Monkey Prices Surge | Harley Finkelstein, John J. Giamatteo, Jeremy Allaire, Mackenzie Burnett
“Demis Hassabis will lean into his role here, focused on using AI to accelerate drug discovery and cure diseases.”
Y Combinator Startup Podcast · Apr 29, 2026
How to Build the Future: Demis Hassabis
“Spun out from DeepMind after AlphaFold2; applying AI to drug discovery, biochemistry, and compound design beyond protein folding”
AI Explained Official Podcast · Apr 24, 2026
GPT 5.5 Arrives, DeepSeek V4 Drops, and the Compute War Intensifies
“Demis Hassabis' drug discovery lab mentioned as promising avenue for meaningful AI breakthroughs”
Moonshots with Peter Diamandis · Feb 19, 2026
Ben Horowitz: xAI Executive Exodus, Apple's AI Crisis, The Pace of AI | #232
“DeepMind subsidiary working on AI-driven scientific discovery and protein design”
Invest Like the Best with Patrick O'Shaughnessy · Feb 18, 2026
Josh Kushner - Concentration and Conviction - [Invest Like the Best, EP.459]
“AI company spun out from DeepMind with Thrive support; focused on drug discovery and disease curing”
The a16z Show · Feb 16, 2026
Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company
“AI company partnering with Novartis on undruggable targets using AlphaFold3”
"The Cognitive Revolution" | AI Builders, Researchers, and Live Player Analysis · Feb 14, 2026
Approaching the AI Event Horizon? Part 2, w/ Abhi Mahajan, Helen Toner, Jeremie Harris, @8teAPi
“Announced predictive model doubling AlphaFold 3 performance on key drug discovery benchmarks”
Latent Space: The AI Engineer Podcast · Feb 12, 2026
🔬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery
“DeepMind spinoff that kept AlphaFold 3 proprietary for commercial drug discovery applications”
My First Million · Jan 19, 2026
Story Of The Most Important Founder You've Never Heard Of
Google DeepMind: The Podcast · Nov 28, 2025
AlphaFold: Grand Challenge to Nobel Prize with John Jumper
“Using AlphaFold for drug design and small molecule discovery; applying structure prediction to therapeutic development”
Lex Fridman Podcast · Jul 23, 2025
#475 – Demis Hassabis: Future of AI, Simulating Reality, Physics and Video Games
“Spun out from DeepMind to apply AlphaFold-like systems to drug discovery and chemistry”